SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
Street Poller Media and The Boom of the Street Interview Ad Industry 
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
Honda, Nissan Eye Shared Vehicle Software Platform by 2029 
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’ 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
Jefferies Names AMEC Top China Semiconductor Equipment Pick 
Add as a preferred source on Google
FALLS CHURCH, Va., April 10, 2018 -- Northrop Grumman Corporation (NYSE:NOC) plans to release its first quarter 2018 financial results on Wednesday, Apr. 25, 2018. You are invited to participate in a conference call following this release. The information is:
| Date: | Wednesday, Apr. 25, 2018 |
| Time: | Noon Eastern time, 9 a.m. Pacific time |
| Call in by 11:45 a.m. Eastern time, 8:45 a.m. Pacific time | |
| Call-in Number: | 1-877-600-7013 – domestic |
| 1-414-238-0944 – international |
A live audio broadcast of the conference call will be available on the Investor Relations page of the Northrop Grumman website at http://www.northropgrumman.com.
For those who cannot participate in this call, it will be archived on the Investor Relations page for a limited time. It will also be recorded and available through Wednesday, May 2, 2018, by calling 1-855-859-2056 (domestic) or 1-404-537-3406 (international). Please use conference ID 2966058.
If you have any questions, please call Steve Movius, vice president, Investor Relations, at 703-280-4575 or Denny McSweeny, director, Investor Relations at 703-280-4578.
